SCHEMBL29231908

SCHEMBL29231908

CCOC(=O)CC[C@@H](C(=O)OCC)N(C=O)c1ccc([N+](=O)[O-])c(Oc2ccccc2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 7/20 0.34
KMT2A Q03164 4/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 2/20 0.34
MERTK Q12866 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PKM P14618 1/20 0.33
CES2 O00748 1/20 0.33
ACHE P22303 1/20 0.33
CES1 P23141 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29231822 0.85 CYP1A2 (0.37) L3MBTL1CYP1A2POLBCYP2C9CYP2C19
SCHEMBL23005124 0.83 EPOR (0.40) PIN1CYP1A2ALDH1A1KMT2AMEN1
SCHEMBL30106811 0.75 ALDH1A1 (0.42) PIN1L3MBTL1POLBALDH1A1KMT2A
SCHEMBL30945383 0.75 ALDH1A1 (0.42) PIN1L3MBTL1POLBALDH1A1KMT2A
SCHEMBL29231911 0.75 ALDH1A1 (0.42) PIN1L3MBTL1POLBALDH1A1KMT2A
SCHEMBL29231851 0.74 ALDH1A1 (0.38) ALDH1A1KMT2AMAPK1MEN1SMN1; SMN2
SCHEMBL23005207 0.73 MEN1 (0.34) L3MBTL1CYP1A2ALDH1A1KMT2AMEN1
SCHEMBL23005150 0.72 CHEK1 (0.30)
SCHEMBL29231796 0.70 L3MBTL1 (0.30) L3MBTL1
SCHEMBL23005185 0.70 FOLH1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218858-B 2, 6-Diamino-3, 4-dihydropyrimidin-4-one derivatives and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-06-18 CN disclosed